Phospholipase D inhibitor enhances radiosensitivity of breast cancer cells

Radiation and drug resistance remain the major challenges and causes of mortality in the treatment of locally advanced, recurrent and metastatic breast cancer. Dysregulation of phospholipase D (PLD) has been found in several human cancers and is associated with resistance to anticancer drugs. In the...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheol Son, Ju, Woo Kang, Dong, Mo Yang, Kwang, Choi, Kang-Yell, Gen Son, Tae, Min, Do Sik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789262/
https://www.ncbi.nlm.nih.gov/pubmed/23989060
http://dx.doi.org/10.1038/emm.2013.75

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789262/
https://www.ncbi.nlm.nih.gov/pubmed/23989060
http://dx.doi.org/10.1038/emm.2013.75

Ejemplares similares